Vimarsana
Biggest News Aggregation in the World

Page 36 - Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Today - Breaking & Trending Today

Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028 - Vimarsana News

Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028

/PRNewswire/ -- "According to the latest research study, the demand for Induced Pluripotent Stem Cells: Global Markets expected to grow from $3.4 billion in...

Weight loss, diabetes drugs not linked to suicidal thoughts: EU probe - Vimarsana News

Weight loss, diabetes drugs not linked to suicidal thoughts: EU probe

The review examined several drugs from Novo Nordisk, including Wegovy, Ozempic, Rybelsus, and Saxenda, but did not include Eli Lilly's Zepbound and Mounjaro.

Source: cnbc.com
Epigenetic Laboratories Partner to Increase Access to Early Cancer Detection Technology, as U.S. Braces for Record High New Cancer Cases - Vimarsana News

Epigenetic Laboratories Partner to Increase Access to Early Cancer Detection Technology, as U.S. Braces for Record High New Cancer Cases

/PRNewswire/ -- As health officials in the United States brace for an all-time record high of new cancer cases in 2024, the demand for access to novel cancer...

Business News: Moderna releases new data on Covid breakthrough cases it says supports need for booster shots - Vimarsana News

Business News: Moderna releases new data on Covid breakthrough cases it says supports need for booster shots

Moderna releases new data on Covid breakthrough cases it says supports need for booster shots : Rashtra News A healthcare worker fills a syringe with Moderna COVID-19 vaccine at the Giorgio Companies site in Blandon, PA where the CATE Mobile Vaccination Unit was onsite to administer Moderna COVID-19 Vaccines to workers Wednesday morning April 14,

J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study - Vimarsana News

J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study

/PRNewswire/ -- J INTS BIO announced the results of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, at the 8th...